
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
Keywords: BBB; blood-brain barrier; CSC; cancer stem cell; GBM; glioblastoma multiforme; H2AX; H2A histone family, member X; scL; tumor-targeted liposome nanocomplex; TMZ; temozolomide; scL-TMZ; scL-encapsulated TMZ nanocomplex; TfR; transferrin receptor; TfRscFv